Thompson Street Capital Partners

St. Louis, Missouri
cb
Founded:2000
Firm Location:St. Louis, Missouri • Panama City, Florida
Investor Firms That Co-Invest with Thompson Street Capital Partners
DeNAAccenturePractical Venture Capital
Thompson Street Capital Partners Team
Photo of Jeff Aiello, Managing Director at Thompson Street Capital Partners
Jeff Aiello
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Jeff
Photo of Craig Albrecht, Managing Director at Thompson Street Capital Partners
Craig Albrecht
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Craig
Photo of Joe Amadio, Managing Director at Thompson Street Capital Partners
Joe Amadio
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Joe
Photo of Elizabeth Borow, Managing Director at Thompson Street Capital Partners
Elizabeth Borow
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
to see your intro paths to Elizabeth
Photo of Cathy Bowers, Investor at Thompson Street Capital Partners
Cathy Bowers
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Cathy
Photo of Max Cannon, Associate at Thompson Street Capital Partners
Max Cannon
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Enterprise (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Max
Photo of Rick Clifton, Managing Director at Thompson Street Capital Partners
Rick Clifton
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in AI (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Rick
Photo of Dan Cooper, Investor at Thompson Street Capital Partners
Dan Cooper
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Dan
Photo of Bob Dunn, Managing Partner at Thompson Street Capital Partners
Bob Dunn
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Digital Health (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Bob
Photo of Kevin Fox, Vice President at Thompson Street Capital Partners
Kevin Fox
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Kevin
Photo of Joe Jedlicka, Senior Associate at Thompson Street Capital Partners
Joe Jedlicka
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Applications (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Enterprise (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Enterprise Applications (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Joe
Photo of Jesse Keipp, Managing Director at Thompson Street Capital Partners
Jesse Keipp
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Digital Health (Series B), Investors in Consumer Internet (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in AI (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Jesse
Photo of Kevin Kerr, Vice President at Thompson Street Capital Partners
Kevin Kerr
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Applications (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in FinTech (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in FinTech (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Kevin
Photo of Brian Kornmann, Managing Director at Thompson Street Capital Partners
Brian Kornmann
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Applications (Series B), Investors in Digital Health (Series B), Investors in Consumer Internet (Series B), Investors in Health & Hospital Services (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Brian
Photo of Alex Mace, Vice President at Thompson Street Capital Partners
Alex Mace
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
to see your intro paths to Alex
Photo of Clayton Milburn, Investor at Thompson Street Capital Partners
Clayton Milburn
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Clayton
Photo of Fade Oluokun, Vice President at Thompson Street Capital Partners
Fade Oluokun
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Fade
Photo of Alison Schulte, Vice President at Thompson Street Capital Partners
Alison Schulte
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Alison
Photo of Jack Senneff, Managing Director at Thompson Street Capital Partners
Jack Senneff
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
to see your intro paths to Jack
Photo of Bradley Strahorn, Investor at Thompson Street Capital Partners
Bradley Strahorn
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
to see your intro paths to Bradley
Photo of Ray Wagner, Managing Director at Thompson Street Capital Partners
Ray Wagner
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Ray
Photo of Vince Warrick, Managing Director at Thompson Street Capital Partners
Vince Warrick
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Midwest (Other Lists)
to see your intro paths to Vince
Photo of J.C. Wetzel, Investor at Thompson Street Capital Partners
J.C. Wetzel
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to J.C.
Photo of Kelly Wittenbrink, Vice President at Thompson Street Capital Partners
Kelly Wittenbrink
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Applications (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Kelly